PubRank

Keitaro Yokoyama

Author PubWeight™ 39.35‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder. Ther Apher Dial 2013 2.07
2 Most patients with coronary artery calcification have no coronary artery stenosis and hyperphosphatemia should be important in reevaluating the K/DOQI guidelines. Ther Apher Dial 2006 1.39
3 A nonclassical vitamin D receptor pathway suppresses renal fibrosis. J Clin Invest 2013 1.16
4 Serum phosphate and calcium should be primarily and consistently controlled in prevalent hemodialysis patients. Ther Apher Dial 2013 1.14
5 Effects of serum calcium, phosphorous, and intact parathyroid hormone levels on survival in chronic hemodialysis patients in Japan. Ther Apher Dial 2008 1.06
6 Autoantibodies against carbonic anhydrase II are increased in renal tubular acidosis associated with Sjogren syndrome. Am J Med 2005 1.03
7 Nafamostat mesilate as an anticoagulant during continuous veno-venous hemodialysis: a three-year retrospective cohort study. Int J Artif Organs 2011 0.95
8 Quantitative assessment of the peritoneal vessel density and vasculopathy in CAPD patients. Nephrol Dial Transplant 2006 0.94
9 The hypothesis that bone turnover influences FGF23 secretion. Kidney Int 2010 0.93
10 Risk factors for encapsulating peritoneal sclerosis in patients who have experienced peritoneal dialysis treatment. Clin Exp Nephrol 2005 0.90
11 Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels. Nephrol Dial Transplant 2007 0.90
12 Phosphate overload accelerates vascular calcium deposition in end-stage renal disease patients. Nephrol Dial Transplant 2003 0.89
13 Gene expression of vitamin D hydroxylase and megalin in the remnant kidney of nephrectomized rats. Kidney Int 2003 0.89
14 Comparison between the pathology of encapsulating sclerosis and simple sclerosis of the peritoneal membrane in chronic peritoneal dialysis. Ther Apher Dial 2008 0.88
15 Low-grade endotoxemia contributes to chronic inflammation in hemodialysis patients: examination with a novel lipopolysaccharide detection method. Ther Apher Dial 2010 0.88
16 Risk factors and preventive measures for encapsulating peritoneal sclerosis--Jikei experience 2002. Adv Perit Dial 2002 0.86
17 Comparison between whole and intact parathyroid hormone assays. Ther Apher Dial 2011 0.85
18 Removal of 2-arachidonylglycerol by direct hemoperfusion therapy with polymyxin B immobilized fibers benefits patients with septic shock. Ther Apher Dial 2008 0.84
19 IRMA (whole PTH) is a more useful assay for the effect of PTH on bone than the Allegro intact PTH assay in CAPD patients with low bone turnover marker. Nephrol Dial Transplant 2003 0.84
20 Nonenzymatic cross-linking pentosidine increase in bone collagen and are associated with disorders of bone mineralization in dialysis patients. Calcif Tissue Int 2011 0.83
21 Anxiety for the influenza of the patient with dialysis: choice of the HD/PD combination therapy. Nephrol Dial Transplant 2010 0.82
22 Plasma cell-rich rejection accompanied by acute antibody-mediated rejection in a patient with ABO-incompatible kidney transplantation. Nephrology (Carlton) 2014 0.82
23 Elevated oxidative stress measured as albumin redox state in continuous ambulatory peritoneal dialysis patients correlates with small uraemic solutes. Nephrol Dial Transplant 2006 0.80
24 Risk factors for encapsulating peritoneal sclerosis in long-term peritoneal dialysis: a retrospective observational study. Ther Apher Dial 2013 0.80
25 Increased lymphatic vessels in patients with encapsulating peritoneal sclerosis. Perit Dial Int 2012 0.79
26 Persistent alpha-Klotho (a-Kl) expression in the parathyroid glands of patients with secondary hyperparathyroidism. Nephrol Dial Transplant 2010 0.79
27 Do serum hepcidin-25 levels correlate with oxidative stress in patients with chronic kidney disease not receiving dialysis? Clin Nephrol 2012 0.79
28 Effect of aliskiren in chronic kidney disease patients with refractory hypertension undergoing hemodialysis: a randomized controlled multicenter study. Clin Exp Nephrol 2013 0.78
29 Intraoperative 99mTc-MIBI-guided detection of ectopic glands in secondary hyperparathyroidism. Int Surg 2010 0.78
30 Detection of dihydropyridine- and voltage-sensitive intracellular Ca(2+) signals in normal human parathyroid cells. J Physiol Sci 2013 0.78
31 The calcium-phosphorus in guidelines for CKD-MBD. Kidney Int 2008 0.77
32 High iron storage levels are associated with increased DNA oxidative injury in patients on regular hemodialysis. Clin Exp Nephrol 2005 0.77
33 Clinical significance of the K/DOQI bone guidelines in Japan. Am J Kidney Dis 2004 0.77
34 Investigation of coronary artery calcification and stenosis by coronary angiography (CAG) in haemodialysis patients. Nephrol Dial Transplant 2005 0.77
35 Peritoneal clearance and transport of methylglyoxal. Nephrol Dial Transplant 2010 0.77
36 Preventive Strategies for Vascular Calcification in Patients with Chronic Kidney Disease. Contrib Nephrol 2016 0.76
37 Restoration of peritoneal integrity after withdrawal of peritoneal dialysis: characteristic features of the patients at risk of encapsulating peritoneal sclerosis. Clin Exp Nephrol 2005 0.76
38 Fifteen cases of encapsulating peritoneal sclerosis related to peritoneal dialysis: a single-center experience in Japan. Adv Perit Dial 2002 0.76
39 [Mechanism and therapy of vascular calcification]. Clin Calcium 2004 0.76
40 Successful treatment of recurrent focal segmental glomerulosclerosis combined with calcineurin inhibitor nephrotoxicity four yr after kidney transplantation. Clin Transplant 2010 0.76
41 Plasma adiponectin: a predictor of coronary heart disease in hemodialysis patients--a Japanese prospective eight-year study. Nephron Clin Pract 2008 0.76
42 The hypothesis that type of species change depends on neutral-pH PD solutions. Kidney Int 2012 0.75
43 Cinacalcet hydrochloride in chronic kidney disease-mineral bone disorder. Clin J Am Soc Nephrol 2009 0.75
44 The hypothesis that abnormal BH₄ metabolism impairs kidney function. Kidney Int 2010 0.75
45 Guidelines and medication compliance. Kidney Int 2012 0.75
46 A reason for choosing peritoneal dialysis: lessons after the Japan earthquake and the Fukushima nuclear accident. Am J Kidney Dis 2012 0.75
47 Successful treatment of nephrotic syndrome caused by recurrent IgA nephropathy with chronic active antibody-mediated rejection three years after kidney transplantation. Clin Transplant 2011 0.75
48 Dialysate temperature adjustment as an effective treatment for baroreflex failure syndrome in hemodialysis patient. BMC Nephrol 2014 0.75
49 A 12-week dose-escalating study of etelcalcetide (ONO-5163/AMG 416), 
a novel intravenous calcimimetic, for secondary hyperparathyroidism in 
Japanese hemodialysis patients
. Clin Nephrol 2017 0.75
50 Acute vascular rejection during antituberculosis therapy in a kidney transplant patient. Nephrology (Carlton) 2014 0.75
51 Decrease of serum sphingosine-1-phosphate levels in hemodialysis patients with secondary hyperparathyroidism treated with cinacalcet. Clin Nephrol 2012 0.75
52 Successful living-related kidney transplantation in hereditary renal hypouricaemia. Nephrol Dial Transplant 2006 0.75
53 Significance of interferon-β for the treatment of hepatitis C virus infection in hemodialyzed patients. Hepatol Res 2010 0.75
54 [Effect of angiotensin II receptor antagonist (losartan) on renal function, serum potassium and blood pressure in patients with advanced renal failure: differences between patients with a serum creatinine (SCr) level higher than 3 mg/dl and those with a lower SCr level]. Nihon Jinzo Gakkai Shi 2002 0.75
55 Low blood osteoprotegerin levels are a predictor to poor prognosis in Japanese patients on hemodialysis due to diabetic nephropathy. Ther Apher Dial 2008 0.75
56 [Dialysis as bridge therapy for renal transplantation: single center experience, a comparison of hemodialysis and continuous ambulatory peritoneal dialysis]. Nihon Jinzo Gakkai Shi 2005 0.75
57 The differences in acid-base status and the calcium parathyroid axis between peritoneal dialysis and hemodialysis. Clin Nephrol 2016 0.75
58 Usefulness of intraoperative 99m Tc-MIBI-guided detection for recurrent sites in secondary hyperparathyroidism: a case-controlled study. Int J Surg 2008 0.75
59 Morning hypertension determined by self-measurement at home predicts left ventricular hypertrophy in patients undergoing continuous ambulatory peritoneal dialysis. Ther Apher Dial 2012 0.75
60 [Long-standing high-transport membrane as a risk factor for EPS development after PD withdrawal: an analysis based on changes in peritoneal function during and after CAPD withdrawal]. Nihon Jinzo Gakkai Shi 2002 0.75
61 Combined therapy with peritoneal dialysis and hemodialysis: a multicenter retrospective observational cohort study in Japan. Blood Purif 2014 0.75
62 Laparoscopic approach for the evaluation of peritoneal injury. Kidney Int 2012 0.75
63 Should the targeted value of the phosphate be reviewed in the normal range from the viewpoint of vascular calcification? Kidney Int 2010 0.75
64 Usefulness of combined application of double-filtration plasmapheresis and twice-daily injections of interferon-β in hemodialysis patients with hepatitis C virus genotype 1b infection and a high viral load. Hepatol Res 2013 0.75
65 [Conception and the control of CKD-MBD]. Nihon Jinzo Gakkai Shi 2007 0.75
66 [Mechanism, imaging technique and therapy for vascular calcification in patients of chronic kidney disease]. Clin Calcium 2007 0.75
67 Successful treatment of BK virus nephropathy using therapeutic drug monitoring of mycophenolic acid. Nephrology (Carlton) 2014 0.75
68 [Risk factors for death in patients starting PD for their first renal replacement therapy]. Nihon Jinzo Gakkai Shi 2009 0.75
69 Surgical verification of percutaneous maxacalcitol injection therapy on enlarged parathyroid glands in chronic dialysis patients. Nephrol Dial Transplant 2003 0.75
70 Extracorporeal bioartificial liver using the radial-flow bioreactor in treatment of fatal experimental hepatic encephalopathy. Artif Organs 2007 0.75
71 A case of BK virus nephropathy and cytomegalovirus infection concurrent with plasma cell-rich acute rejection. Clin Transplant 2012 0.75
72 Monitoring of body water composition by the simultaneous use of bioelectrical impedance analysis and Crit-Line(®) during hemodialysis. Clin Exp Nephrol 2014 0.75
73 Middle molecular uremic substances retention itself might influence the bioincompatibility of PD solution. Kidney Int 2008 0.75
74 Is encapsulating peritoneal sclerosis a threatening issue in continuous ambulatory peritoneal dialysis? The Japanese experience. Perit Dial Int 2003 0.75
75 Generation of a 10.6-THz ultrahigh-repetition-rate train by synthesizing phase-coherent Raman-sidebands. Opt Express 2005 0.75
76 [Case report; A case of familial neurohypophyseal diabetes insipidus revealed after an operation for esophageal achalasia]. Nihon Naika Gakkai Zasshi 2011 0.75
77 A strategy for encapsulating peritoneal sclerosis: pay attention not only to PD solution but also middle molecular uraemic substances retention! Nephrol Dial Transplant 2010 0.75